NEWARK, Del, July 31, 2023 (GLOBE NEWSWIRE) -- The global Non-Mydriatic Fundus Camera Market is expected to grow significantly in the coming years, driven by several factors, including growing prevalence of retinal disorders, increasing demand for non-invasive screening, and enhanced patient outcomes. By 2033, it is anticipated that the non-mydriatic fundus camera market will be worth US$ 563.1 Million. With a value share of almost 56.2%, the hand-held non-mydriatic fundus camera led the global market within the product category in 2022. From 2023 to 2033, it is anticipated to rise at a CAGR of nearly 7.8%.
Non-mydriatic fundus cameras provide a non-invasive imaging solution for capturing detailed retina images. Unlike traditional fundus cameras that require pupil dilation, non-mydriatic cameras can capture high-quality images without mydriasis. This exclusive feature improves patient comfort and convenience during examinations.
Non-mydriatic fundus cameras can be integrated with artificial intelligence (AI) algorithms for automated image analysis. AI-based image analysis aid in early detection and screening of eye diseases, including diabetic retinopathy and age-related macular degeneration. This exclusive feature improves diagnostic accuracy and efficiency.
Seamless integration of non-mydriatic fundus cameras with electronic health record systems improves workflow efficiency and enhances patient care. The direct connection between imaging devices and EHR allows for streamlined documentation, access to historical data, and better care coordination.
Download the Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-17802
Key Takeaways from the Non-Mydriatic Fundus Camera Market Study:
- By product, hand-held non-mydriatic fundus camera accounts for US$ 141.5 Million in 2022 owing to the associated benefits like greater mobility, making it easier to capture fundus images in various clinical settings.
- By sensor technology, the CMOS sensor accounts for US$ 112.3 Million in 2022. CMOS sensors typically have faster data readout capabilities compared to CCD sensors. This allows for quicker image capture, reducing the time required for each examination.
- Hospitals hold about 41.9% of the global market share in 2022. Hospitals often conduct screening programs to identify individuals at risk of developing retinal conditions, especially in cases like diabetic retinopathy.
- By region, North America held a dominant position globally in 2022. Non-mydriatic fundus cameras play a crucial role in teleophthalmology programs, allowing patients to capture their retinal images locally and transmit them to ophthalmologists or retinal specialists for remote interpretation.
“Rising cases of eye disorders and increase in the adoption rate of minimally invasive procedures contribute to its higher demand and global expansion.” says an analyst of Future Market Insights.
Non-mydriatic Fundus Camera Market Competitive Landscape and Their Marketing Strategies:
Leading companies are spending heavily on research & development efforts to create advanced products enhancing effectiveness and patient affordability.
- In February 2023, Sun Pharmaceuticals announced acquiring shares of a 26.9% stake in two digital health businesses- Agatsa Software Pvt. Ltd. and Remidio Innovative Solutions Pvt. Ltd.
- In May 2023, Espansione Group & Topcon Healthcare SEA announced an ongoing exclusive partnership. The whole range of current solutions & upcoming innovations from Espansione Group will be distributed exclusively by Topcon in the Southeast Asian market.
Top Companies:
- Canon Medical Systems, USA.
- Carl Zeiss
- Centervue, Inc.
- Chongqing Vision Star Optical Co., Ltd.
- Forus Health Pvt Ltd,
- Guardion Health Sciences, Inc.
- HAAG-STREIT GROUP
- Huvitz Corp
- ICEN Technology Company Limited
- Kowa American Corporation
- Nanjing Redsun Optical Co., Ltd.
- NIDEK CO., LTD.
- OPTOVUE, INC.
- Remidio Innovative Solutions Pvt Ltd.
- Remidio Innovative Solutions Pvt Ltd.
- Topcon Corporation
- Topcon Medical Systems, Inc.
- Volk Optical
Discover the untapped potential of the Non-mydriatic Fundus Camera Market! Unlock valuable information about each segment by purchasing now: https://www.futuremarketinsights.com/checkout/17802
Country-wise Insights Non-mydriatic Fundus Camera Market
- United States: The United States has a significant demand for advanced medical imaging technologies, including non-mydriatic fundus cameras. The high prevalence of diabetes and an aging population has increased the incidence of diabetic retinopathy and age-related eye conditions, driving the demand for such devices. Additionally, a well-established healthcare infrastructure, insurance coverage for eye examinations, and continuous advancements in technology further contribute to the market's growth.
- Europe: European countries, including Germany, France, and the UK, have a robust healthcare system, and eye care is a significant component of their medical services. The region has seen increased adoption of non-mydriatic fundus cameras due to growing awareness of eye diseases, government initiatives promoting regular eye check-ups, and the presence of key market players in the region.
- China: China's non-mydriatic fundus camera market has witnessed rapid growth over the past few years. The country's large population, increasing prevalence of diabetes, and rising awareness of eye health have contributed to the demand for these devices. Moreover, the Chinese government's efforts to improve healthcare infrastructure and expand access to medical services have further bolstered the market's expansion.
- India: India is experiencing a gradual increase in the adoption of non-mydriatic fundus cameras. The country's large diabetic population and growing middle-class segment with better access to healthcare are driving the demand for these devices. However, the market is still in the early stages of development, and cost concerns remain a limiting factor for broader adoption.
- Japan: Japan's well-established healthcare system and high healthcare spending have led to the early adoption of advanced medical technologies, including non-mydriatic fundus cameras. The country's aging population and government initiatives for early detection of eye diseases have also contributed to market growth.
- Other Regions: Other countries in Asia, Latin America, and the Middle East are gradually recognizing the importance of non-mydriatic fundus cameras for eye health management. Factors like increasing healthcare expenditure, growing awareness of eye diseases, and improvements in medical infrastructure are fostering the market's growth in these regions.
Customize your report by selecting specific countries or regions and save up to 30%! https://www.futuremarketinsights.com/customization-available/rep-gb-17802
Key Market Segments Covered in the Non-mydriatic Fundus Camera Industry Research:
By Product:
- Table-Top Non-Mydriatic Fundus Cameras
- Hand-Held Non-Mydriatic Fundus Cameras
By Sensor Technology:
- CMOS Sensor
- CCD Sensor
- Others
By End User:
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Explore FMI’s related ongoing Coverage in Healthcare Market Domain:
Mobile Gamma Cameras Market: Sales in the global Mobile Gamma Cameras Market are slated to top US$ 57.2 Million in 2022. Expanding at a healthy 4.7% CAGR, the market size is projected to total US$ 75.2 Million by 2028.
Microscope Digital Cameras Market: The global microscope digital cameras market enjoyed a valuation of US$ 675.3 Million in 2021 and it is likely to surpass US$ 741.5 Million by the end of 2022. Furthermore, with rising usage across hospitals, clinics, research laboratories, and the biotechnology industry, the overall sales of digital microscope cameras are projected to surge at a CAGR of 9.1% during the forecast period (2022 to 2032), totaling a valuation of ~US$ 1.76 Billion by 2032.
Wireless Surgical Cameras Market: The global wireless surgical cameras market size is expected to reach US$ 75.1 Million in 2022. Demand is expected to increase at a 7.4% CAGR to reach a valuation of US$ 153.3 Million by 2032.
Pulmonology Devices Market: The global pulmonology devices market is estimated at US$ 1.4 billion in 2023. The market is projected to reach US$ 3.8 billion by 2033, exhibiting a CAGR of 10.3% from 2023 to 2033.
Esophageal Implant Market: The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, the total market value is likely to exceed US$ 280.2 million.
Synchrotron Instrumentation Market: According to Future Market Insights research, during the projected period, the global synchrotron instrumentation market is expected to grow at a CAGR of 5.6%. The market value is projected to increase from US$ 1.05 Billion in 2023 to US$ 1.80 Billion by 2033.
Robotic Lung Biopsy Market: The robotic lung biopsy market size is projected to be worth US$ 408.0 million in 2023. From 2023 to 2033, global robotic lung biopsy demand is forecast to rise at 9.6% CAGR. Total market valuation at the end of 2033 is expected to surpass US$ 1,023.05 million.
Dermatology Excimer Lasers Market: According to Future Market Insights research, during the projected period, the global dermatology excimer lasers market is expected to grow at a CAGR of 11.4%. The market value is projected to increase from US$ 87.7 Million in 2023 to US$ 258.4 Million by 2033.
Image Guided Systems Market: The Global Image Guided Systems Market was valued at US$ 7.23 Billion in 2022 and is expected to reach US$ 17.41 Billion by 2033. The devices segment with a market share of more than 75% has topped the global market within the product category and is expected to grow at a CAGR of close to 8.2% over the forecast period (2023 to 2033).
Dental Crown Removal Market: The dental crown removal market is estimated to secure a valuation of US$ 294.59 million in 2023 and is predicted to reach US$ 461.9 million by 2033. The market is capturing a CAGR of 4.6% during the forecast period.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
